Literature DB >> 2509307

Development of a simple chromogenic factor VIII assay for clinical use.

R J Wagenvoord1, H H Hendrix, H C Hemker.   

Abstract

The aim of this study was the development of a simple chromogenic factor VIII assay for practical clinical use. The criteria that the assay fulfils are: (1) The method is so sensitive that even 1% factor VIII in human plasma is easily detected. (2) The method is linear in the amount of factor VIII from 0 to 200% in plasma. (3) The pipetting scheme is very simple; two reagents are prepared, reagent 1 (factor IXa, thrombin, Ca2+ and phospholipids) and reagent 2 (factor X). Then we pipet at t = 0 s, 100 microliters diluted plasma + 100 microliters reagent 1 in a reaction tube; at t = 30 s, 100 microliters reagent 2 in the same tube and at t = 90 s, 200 microliters of the reaction mixture in a cuvette with 700 microliters EDTA buffer (stop buffer) and the formed factor Xa is measured with a chromogenic substrate. (4) The reaction components are stable during at least a whole working day. Factor VIII was measured in an assay using bovine clotting factors, so one avoids the risk of viral infections, which one might catch by working with clotting factors isolated from human plasma.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2509307     DOI: 10.1159/000215917

Source DB:  PubMed          Journal:  Haemostasis        ISSN: 0301-0147


  1 in total

1.  Evaluation of the Pharmacokinetics, Pharmacodynamics, and Safety of a Single Dose of Emicizumab in Healthy Chinese Subjects.

Authors:  Haiyan Li; Weijiang Zhang; Claire Petry; Lindong Li; Elena Fernandez; Anna Kiialainen; Sheng Feng; Wanling Hsu; Li Li; Yudong Wei; Christophe Schmitt
Journal:  Clin Pharmacol Drug Dev       Date:  2020-05-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.